Transurethral needle ablation of the prostate: Outcome at 1 year

Journal of Endourology

Volumn 13, Issue 10, 1999, Pages 745-750

  Holmes, Michael ^a,c   Stewart, J ^b   Boulton, J B ^a   Chambers, R M ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; HUMAN; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSTATE SURGERY; QUALITY OF LIFE; REOPERATION; SYMPTOMATOLOGY; TRANSURETHRAL NEEDLE ABLATION; TREATMENT FAILURE; URINE FLOW RATE;

EID: 0033403390     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.1999.13.745     Document Type: Article

References (13)

1. Schulman CC, Zlotta AR. Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: Early clinical experience. Urology 1995;45:28-33.
2. Thorpe AC, Cleary J, Coles J, Vernon S, Reynolds J, Neal DE. Deaths and complications following prostatectomy in 1400 men in Northern Region of England. Br J Urol 1994;74:559-565.
3. Goldwasser B, Ramon J, Engelberg S, et al. Transurethral needle ablation (TUNA) of the prostate using low-level radiofrequency energy: An animal experimental study. Eur Urol 1993;24:400-405.
4. Ramon J, Goldwasser B, Schenfeld O, Engelberg S, Rasor JS, Edwards SD. Needle ablation using radiofrequency current as a treatment for benign prostatic hyperplasia: Experimental results in ex vivo human prostate. Eur Urol 1993;24:406-410.
5. Schulman CC, Zlotta AR, Rasor JS, Hourriez L, Noel J-C, Edwards SD. Transurethral needle ablation (TUNA): Safety, feasibility, and tolerance of a new office procedure for treatment of benign prostatic hyperplasia. Eur Urol 1993;24:415-423.
6. Bruskewitz RC, Issa MM, Roehrborn CG, et al: A prospective, randomized 1-year clinical trial comparing transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 1998;159:1588-1593.
7. Rosario DJ, Woo H, Potts KL, Cutinha PE, Hastie KJ, Chapple CR. Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction. Br J Urol 1997;80:579-586.
8. Campo B, Bergamaschi F, Corrada P, Ordesi G. Transurethral needle ablation (TUNA) of the prostate: A clinical and urodynamic evaluation. Urology 1997;49:847-850.
9. Roehrborn CG, Issa MM, Bruskewitz RC, et al. Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study. Urology 1998;51:415-421.
10. Zlotta AR, Peny M-O, Matos C, Schulman CC. Transurethral needle ablation of the prostate: Clinical experience in patients in urinary acute retention. Br J Urol 1996;77:391-397.
11. Roehrborn CG, Burkhard FC, Bruskewitz RC, Issa MM, Perez-Marrero R, Naslund MJ, Shumaker BP. The effects of transurethral needle ablation of the prostate on pressure flow urodynamic parameters: Analysis of the United States randomized study. J Urol 1999;162:92-97.
12. Namasivayam S, Eardley I, Bryan P, Hastie K, Chapple C. 3 Year prospective follow-up of 91 men treated with transurethral needle ablation of prostate (TUNA) (abstract 1512). J Urol 1999;161:390.
13. Steele GS, Sleep DJ. Transurethral needle ablation of the prostate: A urodynamic based study with 2-year follow-up. J Urol 1997;158: 1834-1838.